Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Shop Apotheke Europe NV buy HFH

Start price
€123.90
04.10.21 / 50%
Target price
-
04.10.22
Performance (%)
-60.45%
End price
€49.00
05.10.22
Summary
This prediction ended on 05.10.22 with a price of €49.00. Massive losses of -60.45% were the result for the BUY prediction by HFH. HFH has 50% into this prediction

Shop Apotheke Europe is a German-based online pharmacy that operates in the European market, offering a broad range of pharmaceutical products, health and wellness items, and beauty and personal care products. It provides customers with an easy-to-use platform to purchase goods, as well as convenient delivery options. Shop Apotheke Europe has continuously expanded its operations, including through several acquisitions, and has established itself as a leading player in the rapidly-growing market of online pharmacies. The company is listed on the Frankfurt Stock Exchange and has a market capitalization of over €1 billion.

Performance without dividends (%)
Name 1w 1m 1y
Shop Apotheke Europe NV -2.360% -2.360% 49.706%
iShares Core DAX® 0.160% -1.640% 12.016%
iShares Nasdaq 100 -3.020% -4.715% 37.102%
iShares Nikkei 225® -2.519% -7.621% 18.066%
iShares S&P 500 -1.377% -2.809% 26.536%

According to HFH what are the pros and cons of Shop Apotheke Europe NV for the foreseeable future?

Pros
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Known brand
Cons

Comments by HFH for this prediction

In the thread Shop Apotheke Europe NV diskutieren

Buy Shop Apotheke Europe NV

In the thread Trading Shop Apotheke Europe NV
Prediction Buy
Perf. (%) -60.45%
Target price
Change
Ends at 04.10.22

Die von HFH gewählte maximale Laufzeit wurde überschritten